Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Coverage and awareness of and compliance with mass drug administration for elimination of lymphatic filariasis in Burdwan District, West Bengal, India.

Identifieur interne : 001B92 ( PubMed/Checkpoint ); précédent : 001B91; suivant : 001B93

Coverage and awareness of and compliance with mass drug administration for elimination of lymphatic filariasis in Burdwan District, West Bengal, India.

Auteurs : Rabindra Nath Roy [Inde] ; Aditya Prasad Sarkar ; Raghunath Misra ; Amitava Chakroborty ; Tusar Kanti Mondal ; Kanad Bag

Source :

RBID : pubmed:23930334

Descripteurs français

English descriptors

Abstract

India adopted WHO's strategy of repeated rounds of mass drug administration (MDA) with diethylcarbamazine to eliminate lymphatic filariasis. The present study attempted to assess the coverage and awareness of and compliance with MDA for elimination of lymphatic filariasis in Burdwan district of India, following MDA round in July 2010. A cross-sectional study was conducted among the four randomly-selected clusters in the district of Burdwan, West Bengal, India, covering 603 individuals from 154 households, using a predesigned pretested schedule. The drug distribution coverage, compliance, and effective coverage were 48.76%, 70.07%, and 34.16% respectively. Only 41.4% of the study population was aware of the MDA activity. This evaluation study noted that MDA is restricted to tablet distribution only. There is an urgent need to improve compliance with drug intake through strengthening of the awareness programme involving both government health workers and community volunteers.

PubMed: 23930334


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:23930334

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Coverage and awareness of and compliance with mass drug administration for elimination of lymphatic filariasis in Burdwan District, West Bengal, India.</title>
<author>
<name sortKey="Roy, Rabindra Nath" sort="Roy, Rabindra Nath" uniqKey="Roy R" first="Rabindra Nath" last="Roy">Rabindra Nath Roy</name>
<affiliation wicri:level="1">
<nlm:affiliation>Community Medicine, Burdwan Medical College, India. rabinroynew@gmail.com</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Community Medicine, Burdwan Medical College</wicri:regionArea>
<wicri:noRegion>Burdwan Medical College</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Sarkar, Aditya Prasad" sort="Sarkar, Aditya Prasad" uniqKey="Sarkar A" first="Aditya Prasad" last="Sarkar">Aditya Prasad Sarkar</name>
</author>
<author>
<name sortKey="Misra, Raghunath" sort="Misra, Raghunath" uniqKey="Misra R" first="Raghunath" last="Misra">Raghunath Misra</name>
</author>
<author>
<name sortKey="Chakroborty, Amitava" sort="Chakroborty, Amitava" uniqKey="Chakroborty A" first="Amitava" last="Chakroborty">Amitava Chakroborty</name>
</author>
<author>
<name sortKey="Mondal, Tusar Kanti" sort="Mondal, Tusar Kanti" uniqKey="Mondal T" first="Tusar Kanti" last="Mondal">Tusar Kanti Mondal</name>
</author>
<author>
<name sortKey="Bag, Kanad" sort="Bag, Kanad" uniqKey="Bag K" first="Kanad" last="Bag">Kanad Bag</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="RBID">pubmed:23930334</idno>
<idno type="pmid">23930334</idno>
<idno type="wicri:Area/PubMed/Corpus">001981</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001981</idno>
<idno type="wicri:Area/PubMed/Curation">001981</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001981</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001981</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001981</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Coverage and awareness of and compliance with mass drug administration for elimination of lymphatic filariasis in Burdwan District, West Bengal, India.</title>
<author>
<name sortKey="Roy, Rabindra Nath" sort="Roy, Rabindra Nath" uniqKey="Roy R" first="Rabindra Nath" last="Roy">Rabindra Nath Roy</name>
<affiliation wicri:level="1">
<nlm:affiliation>Community Medicine, Burdwan Medical College, India. rabinroynew@gmail.com</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Community Medicine, Burdwan Medical College</wicri:regionArea>
<wicri:noRegion>Burdwan Medical College</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Sarkar, Aditya Prasad" sort="Sarkar, Aditya Prasad" uniqKey="Sarkar A" first="Aditya Prasad" last="Sarkar">Aditya Prasad Sarkar</name>
</author>
<author>
<name sortKey="Misra, Raghunath" sort="Misra, Raghunath" uniqKey="Misra R" first="Raghunath" last="Misra">Raghunath Misra</name>
</author>
<author>
<name sortKey="Chakroborty, Amitava" sort="Chakroborty, Amitava" uniqKey="Chakroborty A" first="Amitava" last="Chakroborty">Amitava Chakroborty</name>
</author>
<author>
<name sortKey="Mondal, Tusar Kanti" sort="Mondal, Tusar Kanti" uniqKey="Mondal T" first="Tusar Kanti" last="Mondal">Tusar Kanti Mondal</name>
</author>
<author>
<name sortKey="Bag, Kanad" sort="Bag, Kanad" uniqKey="Bag K" first="Kanad" last="Bag">Kanad Bag</name>
</author>
</analytic>
<series>
<title level="j">Journal of health, population, and nutrition</title>
<idno type="ISSN">1606-0997</idno>
<imprint>
<date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent</term>
<term>Age Distribution</term>
<term>Awareness</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Cross-Sectional Studies</term>
<term>Diethylcarbamazine (administration & dosage)</term>
<term>Diethylcarbamazine (therapeutic use)</term>
<term>Elephantiasis, Filarial (drug therapy)</term>
<term>Female</term>
<term>Filaricides (administration & dosage)</term>
<term>Filaricides (therapeutic use)</term>
<term>Health Knowledge, Attitudes, Practice</term>
<term>Humans</term>
<term>India</term>
<term>Male</term>
<term>Patient Compliance (statistics & numerical data)</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adolescent</term>
<term>Connaissances, attitudes et pratiques en santé</term>
<term>Conscience immédiate</term>
<term>Diéthylcarbamazine (administration et posologie)</term>
<term>Diéthylcarbamazine (usage thérapeutique)</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Femelle</term>
<term>Filaricides (administration et posologie)</term>
<term>Filaricides (usage thérapeutique)</term>
<term>Filariose lymphatique (traitement médicamenteux)</term>
<term>Humains</term>
<term>Inde</term>
<term>Mâle</term>
<term>Observance thérapeutique ()</term>
<term>Répartition par âge</term>
<term>Résultat thérapeutique</term>
<term>Études transversales</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Diethylcarbamazine</term>
<term>Filaricides</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Diethylcarbamazine</term>
<term>Filaricides</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en">
<term>India</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr">
<term>Diéthylcarbamazine</term>
<term>Filaricides</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en">
<term>Patient Compliance</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Filariose lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Diéthylcarbamazine</term>
<term>Filaricides</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Age Distribution</term>
<term>Awareness</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Cross-Sectional Studies</term>
<term>Female</term>
<term>Health Knowledge, Attitudes, Practice</term>
<term>Humans</term>
<term>Male</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Connaissances, attitudes et pratiques en santé</term>
<term>Conscience immédiate</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Femelle</term>
<term>Humains</term>
<term>Inde</term>
<term>Mâle</term>
<term>Observance thérapeutique</term>
<term>Répartition par âge</term>
<term>Résultat thérapeutique</term>
<term>Études transversales</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Inde</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">India adopted WHO's strategy of repeated rounds of mass drug administration (MDA) with diethylcarbamazine to eliminate lymphatic filariasis. The present study attempted to assess the coverage and awareness of and compliance with MDA for elimination of lymphatic filariasis in Burdwan district of India, following MDA round in July 2010. A cross-sectional study was conducted among the four randomly-selected clusters in the district of Burdwan, West Bengal, India, covering 603 individuals from 154 households, using a predesigned pretested schedule. The drug distribution coverage, compliance, and effective coverage were 48.76%, 70.07%, and 34.16% respectively. Only 41.4% of the study population was aware of the MDA activity. This evaluation study noted that MDA is restricted to tablet distribution only. There is an urgent need to improve compliance with drug intake through strengthening of the awareness programme involving both government health workers and community volunteers.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">23930334</PMID>
<DateCreated>
<Year>2013</Year>
<Month>08</Month>
<Day>12</Day>
</DateCreated>
<DateCompleted>
<Year>2013</Year>
<Month>08</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2017</Year>
<Month>02</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1606-0997</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>31</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2013</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Journal of health, population, and nutrition</Title>
<ISOAbbreviation>J Health Popul Nutr</ISOAbbreviation>
</Journal>
<ArticleTitle>Coverage and awareness of and compliance with mass drug administration for elimination of lymphatic filariasis in Burdwan District, West Bengal, India.</ArticleTitle>
<Pagination>
<MedlinePgn>171-7</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>India adopted WHO's strategy of repeated rounds of mass drug administration (MDA) with diethylcarbamazine to eliminate lymphatic filariasis. The present study attempted to assess the coverage and awareness of and compliance with MDA for elimination of lymphatic filariasis in Burdwan district of India, following MDA round in July 2010. A cross-sectional study was conducted among the four randomly-selected clusters in the district of Burdwan, West Bengal, India, covering 603 individuals from 154 households, using a predesigned pretested schedule. The drug distribution coverage, compliance, and effective coverage were 48.76%, 70.07%, and 34.16% respectively. Only 41.4% of the study population was aware of the MDA activity. This evaluation study noted that MDA is restricted to tablet distribution only. There is an urgent need to improve compliance with drug intake through strengthening of the awareness programme involving both government health workers and community volunteers.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Roy</LastName>
<ForeName>Rabindra Nath</ForeName>
<Initials>RN</Initials>
<AffiliationInfo>
<Affiliation>Community Medicine, Burdwan Medical College, India. rabinroynew@gmail.com</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sarkar</LastName>
<ForeName>Aditya Prasad</ForeName>
<Initials>AP</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Misra</LastName>
<ForeName>Raghunath</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Chakroborty</LastName>
<ForeName>Amitava</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mondal</LastName>
<ForeName>Tusar Kanti</ForeName>
<Initials>TK</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bag</LastName>
<ForeName>Kanad</ForeName>
<Initials>K</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Bangladesh</Country>
<MedlineTA>J Health Popul Nutr</MedlineTA>
<NlmUniqueID>100959228</NlmUniqueID>
<ISSNLinking>1606-0997</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005369">Filaricides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>V867Q8X3ZD</RegistryNumber>
<NameOfSubstance UI="D004049">Diethylcarbamazine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Trop Biomed. 2006 Dec;23(2):156-62</RefSource>
<PMID Version="1">17322817</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Vector Borne Dis. 2011 Jun;48(2):101-4</RefSource>
<PMID Version="1">21715733</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Indian J Community Med. 2008 Jan;33(1):38-42</RefSource>
<PMID Version="1">19966995</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Vector Borne Dis. 2008 Dec;45(4):313-20</RefSource>
<PMID Version="1">19248659</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trop Med Int Health. 2004 Jun;9(6):702-9</RefSource>
<PMID Version="1">15189460</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parasit Vectors. 2011;4:90</RefSource>
<PMID Version="1">21612649</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017677" MajorTopicYN="N">Age Distribution</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001364" MajorTopicYN="Y">Awareness</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004049" MajorTopicYN="N">Diethylcarbamazine</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005369" MajorTopicYN="N">Filaricides</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007722" MajorTopicYN="Y">Health Knowledge, Attitudes, Practice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007194" MajorTopicYN="N" Type="Geographic">India</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010349" MajorTopicYN="N">Patient Compliance</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC3702337</OtherID>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2013</Year>
<Month>8</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2013</Year>
<Month>8</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2013</Year>
<Month>8</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">23930334</ArticleId>
<ArticleId IdType="pmc">PMC3702337</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Inde</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Bag, Kanad" sort="Bag, Kanad" uniqKey="Bag K" first="Kanad" last="Bag">Kanad Bag</name>
<name sortKey="Chakroborty, Amitava" sort="Chakroborty, Amitava" uniqKey="Chakroborty A" first="Amitava" last="Chakroborty">Amitava Chakroborty</name>
<name sortKey="Misra, Raghunath" sort="Misra, Raghunath" uniqKey="Misra R" first="Raghunath" last="Misra">Raghunath Misra</name>
<name sortKey="Mondal, Tusar Kanti" sort="Mondal, Tusar Kanti" uniqKey="Mondal T" first="Tusar Kanti" last="Mondal">Tusar Kanti Mondal</name>
<name sortKey="Sarkar, Aditya Prasad" sort="Sarkar, Aditya Prasad" uniqKey="Sarkar A" first="Aditya Prasad" last="Sarkar">Aditya Prasad Sarkar</name>
</noCountry>
<country name="Inde">
<noRegion>
<name sortKey="Roy, Rabindra Nath" sort="Roy, Rabindra Nath" uniqKey="Roy R" first="Rabindra Nath" last="Roy">Rabindra Nath Roy</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B92 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001B92 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:23930334
   |texte=   Coverage and awareness of and compliance with mass drug administration for elimination of lymphatic filariasis in Burdwan District, West Bengal, India.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:23930334" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024